Asia Pacific Depth of Anesthesia Monitoring Market

The depth of anesthesia monitoring market in Asia Pacific is expected to grow from US$ 41.50 million in 2021 to US$ 59.42 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028.

The four stages of anesthesia play a critical role in the central nervous system (CNS) depression during surgery. Variations in anesthesia doses or misjudgment of the depth of anesthesia in patients can lead to serious and dangerous consequences. If anesthesia is not deep enough, patients may regain senses during the surgery and suffer from great psychological trauma. However, if too much anesthesia is used, they will go into deep unconsciousness, which is not conducive to their recovery and can even be life-threatening. Therefore, it is important to monitor the depth of anesthesia. The depth of anesthesia monitors plays a significant role in deciding the extent of anesthesia required during surgeries. The increasing prevalence of diabetes, cardiovascular diseases (CVDs), cancer, stroke, bladder cancer, prostate cancer, kidney diseases, and other chronic diseases are associated with the rise in the number of surgical procedures performed across the region. Furthermore, musculoskeletal & connective tissue, circulatory, and digestive operations are the most performed inpatient surgical procedures, comprising 37%, 22%, and 8% of all hospital-based inpatient surgeries performed in 2019, respectively. Additionally, 88% of hospitals offered patient-controlled analgesia, and 67% offered pain management therapy. Thus, a rising number of surgeries using general anesthesia is the major factor driving the depth of anesthesia monitoring market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific depth of anesthesia monitoring market at a substantial CAGR during the forecast period.

Asia Pacific Depth of Anesthesia Monitoring Market Revenue and Forecast to 2028 (US$ Million)
  

Asia Pacific Depth of Anesthesia Monitoring Market Segmentation

The Asia Pacific depth of anesthesia monitoring market is segmented on the basis of purchasing type, product, end user, and country. Based on purchasing type, the market is bifurcated into direct purchase and group purchasing organization. In 2021, the direct purchase segment held a larger share of the market; and it is expected to register a higher CAGR during the forecast period. Based on product, the market is bifurcated into devices and consumables. In 2021, the devices segment held a larger market share; and it is expected to register a higher CAGR in the market during the forecast period. Based on end user, the market is segmented into hospitals, clinics, ambulatory surgery center, and others. In 2021, the hospitals segment held the largest market share; and it is also expected to register the highest CAGR in the market during the forecast period. Further, based on country, the Asia Pacific depth of anesthesia monitoring market is segmented into China, Japan, India, South Korea, Australia, and the Rest of APAC. In 2021, China held the largest market share; and Japan is expected to grow at the fastest CAGR during the forecast period.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Medtronic; GE Healthcare; Masimo; Koninklijke Philips N.V.; FUKUDA DENSHI; 3M; Danmeter APS; Spacelabs Healthcare; and Mennen Medical are among some of the leading companies in the Asia Pacific depth of anesthesia monitoring market.

Asia Pacific Depth of Anesthesia Monitoring Market Strategic Insights

Asia Pacific Depth of Anesthesia Monitoring Market Segmentation Analysis

Asia Pacific Depth of Anesthesia Monitoring Market Report Highlights

Asia Pacific Depth of Anesthesia Monitoring Report Scope

Asia Pacific Depth of Anesthesia Monitoring Market Country and Regional Insights